Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Robert Naclerio to Prostaglandin D2

This is a "connection" page, showing publications Robert Naclerio has written about Prostaglandin D2.

 
Connection Strength
 
 
 
0.618
 
  1. Wagenmann M, Baroody FM, Desrosiers M, Hubbard WC, Ford S, Lichtenstein LM, Naclerio RM. Unilateral nasal allergen challenge leads to bilateral release of prostaglandin D2. Clin Exp Allergy. 1996 Apr; 26(4):371-8.
    View in: PubMed
    Score: 0.170
  2. Naclerio RM. Effects of antihistamines on inflammatory mediators. Ann Allergy. 1993 Sep; 71(3):292-5.
    View in: PubMed
    Score: 0.142
  3. Naclerio RM, Hubbard W, Lichtenstein LM, Kagey-Sobotka A, Proud D. Origin of late phase histamine release. J Allergy Clin Immunol. 1996 Oct; 98(4):721-3.
    View in: PubMed
    Score: 0.044
  4. Shin MH, Baroody F, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. The effect of azelastine on the early allergic response. Clin Exp Allergy. 1992 Feb; 22(2):289-95.
    View in: PubMed
    Score: 0.032
  5. Naclerio RM. Additional properties of cetirizine, a new H1 antagonist. Allergy Proc. 1991 May-Jun; 12(3):187-91.
    View in: PubMed
    Score: 0.030
  6. Wachs M, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Observations on the pathogenesis of nasal priming. J Allergy Clin Immunol. 1989 Oct; 84(4 Pt 1):492-501.
    View in: PubMed
    Score: 0.027
  7. Naclerio RM, Proud D, Kagey-Sobotka A, Freidhoff L, Norman PS, Lichtenstein LM. The effect of cetirizine on early allergic response. Laryngoscope. 1989 Jun; 99(6 Pt 1):596-9.
    View in: PubMed
    Score: 0.027
  8. Pipkorn U, Proud D, Lichtenstein LM, Schleimer RP, Peters SP, Adkinson NF, Kagey-Sobotka A, Norman PS, Naclerio RM. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest. 1987 Oct; 80(4):957-61.
    View in: PubMed
    Score: 0.024
  9. Brown MS, Peters SP, Adkinson NF, Proud D, Kagey-Sobotka A, Norman PS, Lichtenstein LM, Naclerio RM. Arachidonic acid metabolites during nasal challenge. Arch Otolaryngol Head Neck Surg. 1987 Feb; 113(2):179-83.
    View in: PubMed
    Score: 0.023
  10. Naclerio R, Proud D, Peters S, Sobotka AK, Lichtenstein L, Norman P. The role of inflammatory mediators in allergic rhinitis. Ear Nose Throat J. 1986 May; 65(5):206-12.
    View in: PubMed
    Score: 0.021
  11. Naclerio RM, Proud D, Togias AG, Adkinson NF, Meyers DA, Kagey-Sobotka A, Plaut M, Norman PS, Lichtenstein LM. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 Jul 11; 313(2):65-70.
    View in: PubMed
    Score: 0.020
  12. Naclerio RM, Meier HL, Kagey-Sobotka A, Adkinson NF, Meyers DA, Norman PS, Lichtenstein LM. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1983 Oct; 128(4):597-602.
    View in: PubMed
    Score: 0.018
  13. Peters SP, Naclerio RM, Schleimer RP, MacGlashan DW, Pipkorn U, Lichtenstein LM. The pharmacologic control of mediator release from human basophils and mast cells. Respiration. 1986; 50 Suppl 2:116-22.
    View in: PubMed
    Score: 0.005
  14. Creticos PS, Adkinson NF, Kagey-Sobotka A, Proud D, Meier HL, Naclerio RM, Lichtenstein LM, Norman PS. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest. 1985 Dec; 76(6):2247-53.
    View in: PubMed
    Score: 0.005
  15. Togias AG, Naclerio RM, Proud D, Fish JE, Adkinson NF, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985 Oct; 76(4):1375-81.
    View in: PubMed
    Score: 0.005
  16. Schleimer RP, Fox CC, Naclerio RM, Plaut M, Creticos PS, Togias AG, Warner JA, Kagey-Sobotka A, Lichtenstein LM. Role of human basophils and mast cells in the pathogenesis of allergic diseases. J Allergy Clin Immunol. 1985 Aug; 76(2 Pt 2):369-74.
    View in: PubMed
    Score: 0.005
  17. Norman PS, Naclerio RM, Creticos PS, Togias A, Lichtenstein LM. Mediator release after allergic and physical nasal challenges. Int Arch Allergy Appl Immunol. 1985; 77(1-2):57-63.
    View in: PubMed
    Score: 0.005
  18. Peters SP, Naclerio RM, Freeland HS, Togias A, Schleimer RP, MacGlashan DW, Kagey-Sobotka A, Fox CC, Adkinson NF, Lichtenstein LM. Mast cells and mast cell mediators in models of airway disease. Prog Clin Biol Res. 1985; 199:153-61.
    View in: PubMed
    Score: 0.005
  19. Schleimer RP, MacGlashan DW, Peters SP, Naclerio R, Proud D, Adkinson NF, Lichtenstein LM. Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. J Allergy Clin Immunol. 1984 Oct; 74(4 Pt 1):473-81.
    View in: PubMed
    Score: 0.005
  20. Peters SP, Schleimer RP, Kagey-Sobotka A, Naclerio RM, MacGlashan DW, Schulman ES, Adkinson NF, Lichtenstein LM. The role of prostaglandin D2 in IgE-mediated reactions in man. Trans Assoc Am Physicians. 1982; 95:221-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.